REVERIN 275MG DIN 00012521
Health Canada record
| Active ingredient(s) | ROLITETRACYCLINE 275 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intrathecal; Intrapleural; Intra-Articular; Intraperitoneal; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01AA09 ROLITETRACYCLINE |
| Original market date | 31-Dec-1959 |
| Current status date | 12-Dec-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Request a quote for REVERIN 275MG